ACAD
39.46
+0.33
+0.84%
AEMD
7.61
-0.12
-1.55%
APRI
1.76
+0.15
+9.32%
ARNA
2.74
-0.01
-0.36%
ATEC
0.58
-0.01
-1.69%
CNAT
3.84
-0.01
-0.26%
CRXM
0.35
+0.01
+2.94%
CYTX
0.357
-0.013
-3.4865%
DXCM
88.31
+0.3
+0.34%
GNMK
9.58
+0.07
+0.74%
HALO
16.89
+0.04
+0.24%
ILMN
193.16
-2.29
-1.17%
INNV
0.101
+0.00
+0.0990%
INO
7.11
+0.02
+0.28%
ISCO
3.5
-0.08
-2.23%
ISIS
52.1
+0.53
+1.03%
LGND
89.85
+0.91
+1.02%
LPTN
0.26
+0.01
+4.00%
MBVX
1.6
-0.05
-3.03%
MEIP
1.85
-0.06
-3.14%
MNOV
3.15
-0.01
-0.32%
MRTX
25.85
-0.13
-0.50%
MSTX
0.469
-0.001
-0.213%
NBIX
48.55
+0.46
+0.96%
NUVA
51.21
-0.48
-0.93%
ONCS
5.85
+0.04
+0.69%
ONVO
2.53
+0.03
+1.20%
OREX
2.64
-0.11
-4.00%
OTIC
22.1
+0.54
+2.50%
QDEL
20.87
+0.11
+0.53%
RCPT
231.96
0.00
0.00%
RGLS
8.63
+0.18
+2.13%
RMD
51.17
-0.46
-0.89%
SCIE
0.014
0.00
0.00%
SPHS
0.84
0.00
0.00%
SRNE
12.88
+0.17
+1.34%
TROV
5.85
-0.09
-1.52%
VICL
0.605
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
19.76
+0.13
+0.66%
ACAD
39.46
+0.33
+0.84%
AEMD
7.61
-0.12
-1.55%
APRI
1.76
+0.15
+9.32%
ARNA
2.74
-0.01
-0.36%
ATEC
0.58
-0.01
-1.69%
CNAT
3.84
-0.01
-0.26%
CRXM
0.35
+0.01
+2.94%
CYTX
0.357
-0.013
-3.4865%
DXCM
88.31
+0.3
+0.34%
GNMK
9.58
+0.07
+0.74%
HALO
16.89
+0.04
+0.24%
ILMN
193.16
-2.29
-1.17%
INNV
0.101
+0.00
+0.0990%
INO
7.11
+0.02
+0.28%
ISCO
3.5
-0.08
-2.23%
ISIS
52.1
+0.53
+1.03%
LGND
89.85
+0.91
+1.02%
LPTN
0.26
+0.01
+4.00%
MBVX
1.6
-0.05
-3.03%
MEIP
1.85
-0.06
-3.14%
MNOV
3.15
-0.01
-0.32%
MRTX
25.85
-0.13
-0.50%
MSTX
0.469
-0.001
-0.213%
NBIX
48.55
+0.46
+0.96%
NUVA
51.21
-0.48
-0.93%
ONCS
5.85
+0.04
+0.69%
ONVO
2.53
+0.03
+1.20%
OREX
2.64
-0.11
-4.00%
OTIC
22.1
+0.54
+2.50%
QDEL
20.87
+0.11
+0.53%
RCPT
231.96
0.00
0.00%
RGLS
8.63
+0.18
+2.13%
RMD
51.17
-0.46
-0.89%
SCIE
0.014
0.00
0.00%
SPHS
0.84
0.00
0.00%
SRNE
12.88
+0.17
+1.34%
TROV
5.85
-0.09
-1.52%
VICL
0.605
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
19.76
+0.13
+0.66%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.